financetom
Business
financetom
/
Business
/
BlackRock's Bold Quarter: EPS Tops, $11.6 Trillion AUM, $84 Billion Inflows Power Growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BlackRock's Bold Quarter: EPS Tops, $11.6 Trillion AUM, $84 Billion Inflows Power Growth
Apr 11, 2025 6:36 AM

Investment giant BlackRock ( BLK ), Inc. stock is trading higher after the company reported first-quarter 2025 results.

Revenue grew 12% year over year (Y/Y) to $5.28 billion, missing the consensus of $5.60 billion. 

Investment advisory, administration fees and securities lending revenues increased to $4.4 billion from $3.8 billion a year ago, led by higher organic base fees, the impact of market beta on average AUM, and around $285 million of fees related to the GIP Transaction.

Technology services and subscription revenue rose to $436 million from $377 million the prior year, led by continued demand for Aladdin technology offerings and the closing of the acquisition of Preqin Holding Limited in March 2025 (which added around $20 million to the revenues).

BlackRock ( BLK ) stated that net inflow stood at $84 billion in the quarter, reflecting 3% annualized organic asset growth, driven by a record first quarter for iShares ETFs, along with private markets and active net inflows.

At the end of the quarter, total AUM was $11.6 trillion, compared to $10.5 trillion in the prior year quarter.

Adjusted operating income rose 14% Y/Y to $2.03 billion, with the margin expanding to 43.2% from 42.2% a year ago.

Adjusted EPS increased 15% Y/Y to $11.30, beating the consensus of $11.14.

BlackRock ( BLK ) repurchased shares worth $375 million in the quarter and raised the cash dividend per share by 2% to $5.21.

Laurence D. Fink, chairman and CEO, said, ”We delivered 6% organic base fee growth in the first quarter, representing our best start to a year since 2021 and secular strength against a complex market backdrop.”

Read: US Stocks Likely To Open Lower As Volatility Persists Before Bank Earnings: ‘Fed Is Likely To Cut Rates Again On June 18th,’ Says Expert

"Uncertainty and anxiety about the future of markets and the economy are dominating client conversations. We’ve seen periods like this before when there were large, structural shifts in policy and markets – like the financial crisis, COVID, and surging inflation in 2022,” Fink added.

Investors can gain exposure to the stock via Fidelity Disruptive Finance ETF ( FDFF ) and Schwab US Dividend Equity ETF .

Price Action: BLK shares are up 1.31% at $870.00 premarket at the last check on Friday.

Read Next:

Wall Street Braces For High-Stakes Friday With Bank Earnings, Inflation Data, Consumer Sentiment In Focus

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
States sue US to block rule requiring oil industry to pay for dismantling old wells
States sue US to block rule requiring oil industry to pay for dismantling old wells
Jun 17, 2024
HOUSTON (Reuters) - Texas, Louisiana and Mississippi on Monday sued the U.S. government to block the Biden administration's proposed rule that would require the offshore oil and gas industry to provide nearly $7 billion in funds to cover costs of dismantling old infrastructure. The rule, which would go into effect later this year, applies to companies that do not have...
Ackroo Renewing its Normal-Course Issuer Bid
Ackroo Renewing its Normal-Course Issuer Bid
Jun 17, 2024
11:46 AM EDT, 06/17/2024 (MT Newswires) -- Ackroo ( AKRFF ) on Monday said it is seeking exchange approval to repurchase and cancel up to 5.770 million shares over the next year in a renewed normal-course issuer bid. The payments-systems company said the allowed amount represents 5% of its outstanding shares. The company expects to renewed NCIB to take effect...
Mirum Pharmaceuticals Advances after Reporting Positive Trial Results for Prospective Cholangitis Treatment
Mirum Pharmaceuticals Advances after Reporting Positive Trial Results for Prospective Cholangitis Treatment
Jun 17, 2024
11:42 AM EDT, 06/17/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) rose more than 16% in Monday trading after reporting positive interim results for its volixibat drug candidate during phase 2b testing in patients experiencing inflammation of their bile duct systems. According to the company, patients with either primary biliary or sclerosing cholangitis who were treated with the oral...
Why Allego Shares Are Moving Higher Monday
Why Allego Shares Are Moving Higher Monday
Jun 17, 2024
Allego ( ALLG ) stock is moving higher Monday after its majority shareholder, Meridiam, announced a transaction framework agreement. The Details: Under the transaction framework agreement, Meridiam will launch a tender offer for all outstanding ordinary shares of Allego ( ALLG ) that are not owned by Meridiam or its affiliates. The tender offer price is $1.70 per share, representing...
Copyright 2023-2025 - www.financetom.com All Rights Reserved